Lazard Asset Management
ZYME icon

Lazard Asset Management’s Zymeworks ZYME Stock Holding History

Lazard Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,602
Closed -$265K – 2151
2026
Q1 		$265K Sell
10,602
-3,174
-23% -$75.1K ﹤0.01% 1545
2025
Q4 		$363K Sell
13,776
-1,532
-10% -$33.4K ﹤0.01% 1474
2025
Q3 		$261K Buy
+15,308
New +$219K ﹤0.01% 1528
2025
Q2 		– Sell
-3,787
Closed -$45K – 2564
2025
Q1 		$45K Buy
+3,787
New +$51.6K ﹤0.01% 2019
2024
Q4 		– Sell
-9,561
Closed -$119K – 2576
2024
Q3 		$119K Buy
+9,561
New +$104K ﹤0.01% 1744
2024
Q2 		– Sell
-6,057
Closed -$63K – 2454
2024
Q1 		$63K Sell
6,057
-22,014
-78% -$244K ﹤0.01% 1675
2023
Q4 		$290K Buy
28,071
+12,242
+77% +$97.6K ﹤0.01% 1272
2023
Q3 		$99K Sell
15,829
-16,154
-51% -$119K ﹤0.01% 1638
2023
Q2 		$275K Buy
31,983
+9,335
+41% +$83.6K ﹤0.01% 1252
2023
Q1 		$204K Buy
22,648
+5,020
+28% +$43.8K ﹤0.01% 1309
2022
Q4 		$138K Hold
17,628
– – ﹤0.01% 1402
2022
Q3 		$108K Hold
17,628
– – ﹤0.01% 1441
2022
Q2 		$93K Buy
17,628
+7,511
+74% +$45.4K ﹤0.01% 1534
2022
Q1 		$66K Buy
+10,117
New +$90.2K ﹤0.01% 1607

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Lazard Asset Management's ZYME Position: Q2 2026 in Review

Lazard Asset Management sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 10,602 shares — an estimated $265K sold.

Lazard Asset Management first reported a position in ZYME in Q1 2022 and held it in 14 quarters. The position peaked at $363K in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Lazard Asset Management reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 10,602 Zymeworks shares in Q2 2026, an estimated $265K.
  • Lazard Asset Management first reported a position in Zymeworks in Q1 2022 and held it in 14 quarters.
  • Lazard Asset Management's Zymeworks position peaked at $363K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.